Company News

Health Care Providers Report Ease of Use, and Preference for the PharmaJet Needle-Free Injector

GOLDEN, Colo. – March 17, 2015 – PharmaJet, the maker of innovative needle-free technology, today announced survey data revealing that healthcare providers (HCPs) would recommend the needle-free injector to colleagues and believed that the use of such a device had the capacity to increase vaccination compliance. Details

Survey Reveals Consumer Preference for the PharmaJet Needle-Free Flu Shot

GOLDEN, Colo. – February 26, 2015– Today, PharmaJet, the maker of innovative, needle-free injector technology, announced the release of survey data demonstrating consumer satisfaction with the PharmaJet Needle-Free Injector for seasonal flu vaccinations. Details

Clinical Findings Published in The Lancet Support Administration of Flu Vaccine with PharmaJet’s Needle-Free Injector

GOLDEN, Colo. – September 30, 2014 – A clinical study published in the August 23, 2014 issue of The Lancet demonstrated that delivery of AFLURIA® (Influenza Vaccine) with the PharmaJet Needle-Free Injector compared favorably to traditional needle and syringe delivery. The U.S. Food and Drug Administration (FDA) recently approved the Stratis® 0.5mL Needle-Free Jet Injector... Details

FDA Approves Use of Afluria®, Influenza Vaccine with PharmaJet’s Needle-Free Injector

KING OF PRUSSIA, Penn. / GOLDEN, Colo. – August 19, 2014 – PharmaJet^® Inc., the developer of a needle-free injection technology to administer medications and vaccines to patients, and bioCSL Inc., the maker of AFLURIA^® (Influenza Vaccine) today announced the U.S. Food and Drug Administration (FDA) has approved the PharmaJet Stratis^® 0.5mL Needle-Free Jet Injector... Details

PharmaJet Enters into Strategic Collaboration with CureVac for Needle-Free Delivery of RNA-Based Vaccines

GOLDEN, Colo. – Feb. 22, 2013 – PharmaJet Inc. has entered into a collaboration agreement with CureVac GmbH for delivery of CureVac’s mRNA-based vaccine portfolio including targets in oncology and infectious diseases, using the PharmaJet needle-free jet injector platform. Details

PharmaJet’s Stratis® Needle-Free Injector Receives WHO PQS Certification as a Pre-qualified Delivery Device for Vaccine Administration

GOLDEN, Colo. – Feb. 20, 2013 – PharmaJet Inc. has become the first and only needle-free injection company to receive Performance, Quality and Safety (PQS) pre-qualified certification from the World Health Organization (WHO). Details

PharmaJet Enters into Strategic Collaboration with CSL Limited for Needle‐free Delivery of Influenza Vaccines

GOLDEN, Colo. ‐ Nov. 29, 2012 – PharmaJet Inc. has entered into a collaboration with CSL Limited to enable Afluria® influenza vaccine to be delivered with the PharmaJet Stratis® needle‐free jet injector, as soon as the 2013‐2014 flu season. Details

2011 Colorado Companies to Watch Winner

GOLDEN, Colo. – June 30, 2011 – Now in its third year, Colorado Companies to Watch attracted over 360 nominees. With nearly 100 companies selected as finalists, PharmaJet prevailed along with 49 others to receive the distinction of... Details

Ernst & Young Entrepreneur Of The Year 2011

Golden, CO – May 23, 2011 – PharmaJet® today announced that Chairman, Heather Callender-Potters is an Ernst & Young Entrepreneur Of The Year® 2011 finalist. Details

FDA Grants PharmaJet 510(k) Clearance on Intradermal Needle-Free Injection Device

GOLDEN, Colo. – March 22, 2011 – The U.S. Food and Drug Administration (FDA) has awarded PharmaJet 510(k) clearance to market a 0.1mL Intradermal (ID) Needle-free Injection System. Details